Timing of nimodipine therapy for the treatment of vocal fold paralysis

Laryngoscope. 2015 Jan;125(1):186-90. doi: 10.1002/lary.24903. Epub 2014 Sep 17.

Abstract

Objectives/hypothesis: To retrospectively determine optimal timing for initiation of nimodipine within a cohort of patients with acute vocal fold paralysis (VFP).

Study design: Retrospective patient review.

Methods: Subjects were divided into three groups: initiation within 15 days postinjury (n = 19), between 15 and 30 days postinjury (n = 23), or greater than 30 days postinjury (n = 11).

Results: Fifty-one patients (53 paralyzed vocal folds [VFs]) met entrance criteria and were offered and started off-label nimodipine treatment. Thirty-six of 53 VFs recovered purposeful motion (67.9%). There was no significant difference in the rate of VF recovery among patients who began nimodipine within 15 days (68.4%), patients who started nimodipine between 15 and 30 days (73.9%) of nerve injury (P = .1405), and patients who initiated nimodipine after 30 days postinjury (54.5%).

Conclusions: Nimodipine treatment for acute VFP yielded equal VF motion recovery rates regardless of when the medication was initiated. Time to recovery of motion was not different between groups studied.

Keywords: Nimodipine; laryngeal electromyography; laryngeal muscle innervation; nerve regeneration/drug effects; timing; vocal cord paralysis.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Calcium Channel Blockers / administration & dosage*
  • Calcium Channel Blockers / adverse effects
  • Drug Administration Schedule
  • Electromyography / drug effects
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nimodipine / administration & dosage*
  • Nimodipine / adverse effects
  • Off-Label Use
  • Prognosis
  • Prospective Studies
  • Recurrent Laryngeal Nerve Injuries / drug therapy*
  • Retrospective Studies
  • Time Factors
  • Vocal Cord Paralysis / drug therapy*

Substances

  • Calcium Channel Blockers
  • Nimodipine